Home
Capital Research Global Investors reported a 4.8% stake in Biomarin Pharmaceutical BMRN · 9,150,655 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.8%
- Last report
- 6.8% · filed 25/02/13
- Shares held
- 9,150,655 sh
- Class
- Common Stock
- Event date
- 25/03/31
- Filed
- 25/05/13
4.8% stake · below 5%
- Stake
- 4.8%
- Last report
- 6.8%
- Since last report
- −2.0pp
Biomarin Pharmaceutical trades, last 26 weeks
What else happened in Biomarin Pharmaceutical around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Capital Research Global Investors's other 5% stake reports
- Capital Research Global Investors
5% stakePatria Investments
5% stakePatria Investments
PAX
0% stake
0 sh
0% stake
Filed 09/04
- Capital Research Global Investors
5% stakeBBB Foods
5% stakeBBB Foods
TBBB
7% stake
5,422,899 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeQuantinuum
5% stakeQuantinuum
QNT
5.3% stake
1,754,325 sh
5.3% stake
Filed 08/12
- Capital Research Global Investors
5% stakeXPO
5% stakeXPO
XPO
7% stake
8,271,824 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeDominion Energy
5% stakeDominion Energy
D
8.4% stake
73,865,685 sh
8.4% stake
Filed 08/12
